Table 2.
Outcomes sorted by groups
| Group A* (n=19) |
Group B** (n=28) | Overall (n=47) | p-value | |
|---|---|---|---|---|
| Technical success | ||||
| n (%) | 19/19 (100%) | 28/28 (100%) | 47/47 (100%) | |
| Pre-procedure ODI | ||||
| mean ± SD | 32.42 ± 8.53 | 35.64 ± 12.41 | 34.34 ± 11.01 | 0.33 |
| 1-month follow-up ODI | ||||
| mean ± SD | 20.84 ± 8.55 | 14.71 ± 7.74 | 16.89 ± 8.13 | 0.014 |
| 1-month ODI mean reduction | ||||
| mean ± SD | 11.58 ± 9.51 | 20.93 ± 10.53 | 17.57 ± 11.68 | 0.003 |
| 3-month follow-up ODI | ||||
| mean ± SD | 11.68 ± 7.16 | 13.14 ± 8.06 | 12.55 ± 7.66 | 0.53 |
| 3-month ODI mean reduction | ||||
| Mean ± SD | 20.63 ± 9.87 | 22.07 ± 11.36 | 21.66 ± 5.90 | 0.66 |
| Clinical success (3-month) | ||||
| n (%) | 16/19 (84.21%) | 24/28 (85.71%) | 58/68 (85.11%) | 0.43 |
n number of patients, SD standard deviation, min minutes
*Group A: patients with history of COVID-19 infection
** Group B: patients never affected by COVID-19